Trexquant Investment’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$971K Buy
10,156
+6,948
+217% +$633K 0.01% 1472
2026
Q1
$309K Sell
3,208
-1,112
-26% -$111K ﹤0.01% 1589
2025
Q4
$420K Buy
+4,320
New +$371K ﹤0.01% 1377
2025
Q2
Sell
-8,036
Closed -$422K 1708
2025
Q1
$422K Sell
8,036
-3,839
-32% -$216K ﹤0.01% 1325
2024
Q4
$653K Buy
11,875
+1,592
+15% +$83.8K 0.01% 1211
2024
Q3
$517K Sell
10,283
-6,316
-38% -$291K 0.01% 1242
2024
Q2
$729K Sell
16,599
-1,978
-11% -$84.1K 0.01% 1117
2024
Q1
$817K Buy
18,577
+13,708
+282% +$606K 0.02% 988
2023
Q4
$231K Sell
4,869
-6,827
-58% -$287K 0.01% 1311
2023
Q3
$519K Buy
11,696
+6,553
+127% +$304K 0.01% 1002
2023
Q2
$246K Sell
5,143
-7,893
-61% -$356K 0.01% 1254
2023
Q1
$513K Buy
+13,036
New +$474K 0.01% 987
2022
Q2
Sell
-4,900
Closed -$220K 1673
2022
Q1
$220K Buy
+4,900
New +$227K 0.01% 1157
2021
Q4
Sell
-6,882
Closed -$231K 1454
2021
Q3
$231K Buy
+6,882
New +$234K 0.02% 883

Other funds holding IRMD

Trexquant Investment's IRMD Position: Q2 2026 in Review

Trexquant Investment increased its iRadimed (IRMD) stake by 217% in Q2 2026, buying an estimated $633K and bringing the position to 10,156 shares worth $971K. The position accounts for 0.01% of the portfolio, ranked #1472.

Trexquant Investment first reported a position in IRMD in Q3 2021 and has held it in 14 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Trexquant Investment held 10,156 shares of iRadimed worth $971K as of Q2 2026.
  • Trexquant Investment bought 6,948 iRadimed shares in Q2 2026, an estimated $633K.
  • iRadimed made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1472 holding.
  • Trexquant Investment first reported a position in iRadimed in Q3 2021 and has held it in 14 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.